copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Ozempic Maker’s Stock Plunges 20% After Profit Warning Ozempic Maker’s Stock Plunges 20% After Profit Warning Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States
Ozempic and Wegovy maker Novo Nordisk sees shares tumble on . . . More than 60 billion euros (£52 billion) has been wiped off the stock market value of Ozempic and Wegovy weight loss drug firm Novo Nordisk after it warned over sales and profits as competition ramps up in the US Novo Nordish saw shares plunge by over a fifth following the alert, with the group
Ozempic Maker Novo Nordisk’s Market Value Drops $93 Billion The slashed forecast reflects competition for both Wegovy and its sister drug Ozempic for diabetes, the company said The drugmaker also cited slower than expected market growth for weight-loss drugs Novo’s sales climbed 18 percent in constant currencies in the second quarter, the company said, with operating profit rising 40 percent